Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: To investigate whether serum Wisteria floribunda agglutinin-positive human Mac-2-binding protein (WFA+-M2BP) can predict the recurrence of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) after curative resection. Methods: Patients with chronic hepatitis B (CHB) who underwent curative resection for HCC between 2004 and 2015 were eligible for the study. Recurrence was sub-classified as early (<2 years) or late (≥2 years). Results: A total of 170 patients with CHB were selected. During the follow-up period (median, 22.6 months), 64 (37.6%) patients developed recurrence. In multivariate analyses, WFA+-M2BP level was an independent predictor of overall (hazard ratio [HR]=1.490), early (HR=1.667), and late recurrence (HR=1.416), together with male sex, des-gamma carboxyprothrombin level, maximal tumor size, portal vein invasion, and satellite nodules (all P<0.05). However, WFA+- M2BP level was not predictive of grade B-C posthepatectomy liver failure. The cutoff value that maximized the sum of sensitivity (30.2%) and specificity (90.6%) was 2.14 (area under receiver operating characteristic curve=0.632, P=0.010). Patients with a WFA+-M2BP level >2.14 experienced recurrence more frequently than those with a WFA+-M2BP level ≤2.14 (P=0.011 by log-rank test), and had poorer postoperative outcomes than those with a WFA+-M2BP level ≤2.14 in terms of overall recurrence (56.0 vs. 34.5%, P=0.047) and early recurrence (52.0 vs. 20.7%, P=0.001). Conclusions: WFA+-M2BP level is an independent predictive factor of HBV-related HCC recurrence after curative resection. Further studies should investigate incorporation of WFA+-M2BP level into tailored postoperative surveillance strategies for patients with CHB.
Abstract
Background/Aims: To investigate whether serum Wisteria floribunda agglutinin-positive human Mac-2-binding protein (WFA+-M2BP) can predict the recurrence of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) after curative resection. Methods: Patients with chronic hepatitis B (CHB) who underwent curative resection for HCC between 2004 and 2015 were eligible for the study. Recurrence was sub-classified as early (<2 years) or late (≥2 years). Results: A total of 170 patients with CHB were selected. During the follow-up period (median, 22.6 months), 64 (37.6%) patients developed recurrence. In multivariate analyses, WFA+-M2BP level was an independent predictor of overall (hazard ratio [HR]=1.490), early (HR=1.667), and late recurrence (HR=1.416), together with male sex, des-gamma carboxyprothrombin level, maximal tumor size, portal vein invasion, and satellite nodules (all P<0.05). However, WFA+- M2BP level was not predictive of grade B-C posthepatectomy liver failure. The cutoff value that maximized the sum of sensitivity (30.2%) and specificity (90.6%) was 2.14 (area under receiver operating characteristic curve=0.632, P=0.010). Patients with a WFA+-M2BP level >2.14 experienced recurrence more frequently than those with a WFA+-M2BP level ≤2.14 (P=0.011 by log-rank test), and had poorer postoperative outcomes than those with a WFA+-M2BP level ≤2.14 in terms of overall recurrence (56.0 vs. 34.5%, P=0.047) and early recurrence (52.0 vs. 20.7%, P=0.001). Conclusions: WFA+-M2BP level is an independent predictive factor of HBV-related HCC recurrence after curative resection. Further studies should investigate incorporation of WFA+-M2BP level into tailored postoperative surveillance strategies for patients with CHB.
참고문헌 (32)
- Yu SJ, "A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world : 2010-2016", Clin Mol Hepatol, 22, pp.7~17 (2016)
- Han DH, "Lesson from 610 liver resections of hepatocellular carcinoma in a single center over 10 years", World J Surg Oncol, 12, pp.192~ (2014)
- Imamura H, "Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy", J Hepatol, 38, pp.200~207 (2003)
- Poon RT, "Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma", Cancer, 89, pp.500~507 (2000)
- Kim SU, "Prediction of postoperative hepatic insufficiency by liver stiffness measurement(FibroScan((R)))before curative resection of hepatocellular carcinoma : a pilot study", Hepatol Int, 2, pp.471~477 (2008)
- Shen Y, "Liver stiffness assessed by shear wave elastography predicts postoperative liver failure in patients with hepatocellular carcinoma", J Gastrointest Surg, 21, pp.1471~1479 (2017)
- Jung KS, "Liver stiffness value-based risk estimation of late recurrence after curative resection of hepatocellular carcinoma : development and validation of a predictive model", PloS One, 9, pp.e99167~ (2014)
- Kim SU, "Clinical application of liver stiffness measurement using transient elastography : a surgical perspective", Digestion, 88, pp.258~265 (2013)
- Cescon M, "Value of transient elastography measured with FibroScan in predicting the outcome of hepatic resection for hepatocellular carcinoma", Ann Surg, 256, pp.706~712 (2012)
- Heo JY, "Use of Wisteria floribunda agglutinin-positive human Mac-2 binding protein in assessing risk of hepatocellular carcinoma due to hepatitis B virus", Medicine(Baltimore), 95, pp.e3328~ (2016)
- Kim SU, "Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development", Liver Int, 37, pp.879~887 (2017)
- Toyoda H, "Serum WFA+-M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection", Liver Int, 36, pp.293~301 (2016)
- Kuno A, "Reconstruction of a robust glycodiagnostic agent supported by multiple lectin-assisted glycan profiling", Proteomics Clin Appl, 7, pp.642~647 (2013)
- Korean Liver Cancer Study Group, "Practice guidelines for management of hepatocellular carcinoma 2009", Korean J Hepatol, 15, pp.391~423 (2009)
- Kim BK, "Applicability of BCLC stage for prognostic stratification in comparison with other staging systems : single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma", Liver Int, 32, pp.1120~1127 (2012)
- Korean Association for the Study of the Liver, "KASL clinical practice guidelines: management of chronic hepatitis B", Clin Mol Hepatol, 18, pp.109~162 (2012)
- Rahbari NN, "Posthepatectomy liver failure : a definition and grading by the International Study Group of Liver Surgery(ISGLS)", Surgery, 149, pp.713~724 (2011)
- Dindo D, "Classification of surgical complications : a new proposal with evaluation in a cohort of 6336 patients and results of a survey", Ann Surg, 240, pp.205~213 (2004)
- Batts KP, "Chronic hepatitis. An update on terminology and reporting", Am J Surg Pathol, 19, pp.1409~1417 (1995)
- Bekki Y, "Hepatic stellate cells secrete WFA+-M2BP : its role in biological interactions with Kupffer cells", J Gastroenterol Hepatol, 32, pp.1387~1393 (2017)
- Kuno A, "A serum"sweet-doughnut"protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis", Sci Rep, 3, pp.1065~ (2013)
- Zou X, "Serum WFA+-M2BP levels for evaluation of early stages of liver fibrosis in patients with chronic hepatitis B virus infection", Liver Int, 37, pp.35~44 (2017)
- Yamasaki K, "Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients", Hepatology, 60, pp.1563~1570 (2014)
- Abe M, "Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease", J Gastroenterol, 50, pp.776~784 (2015)
- Yamada N, "Serum Mac-2 binding protein glycosylation isomer predicts grade F4 liver fibrosis in patients with biliary atresia", J Gastroenterol, 52, pp.245~252 (2017)
- Fujiyoshi M, "Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma", J Gastroenterol, 50, pp.1134~1144 (2015)
- Nishikawa H, "Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein for patients with chronic hepatitis B and C : a comparative study", J Viral Hepat, 23, pp.977~984 (2016)
- Kim SU, "Histological subclassification of cirrhosis can predict recurrence after curative resection of hepatocellular carcinoma", Liver Int, 34, pp.1008~1017 (2014)
- Jung KS, "Prediction of recurrence after curative resection of hepatocellular carcinoma using liver stiffness measurement(FibroScan(R))", Ann Surg Oncol, 19, pp.4278~4286 (2012)
- Seo YS, "Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis : a multicentre, retrospective study", Liver Int, 35, pp.2246~2255 (2015)
- Okuda Y, "Usefulness of Mac-2 binding protein glycosylation isomer for prediction of posthepatectomy liver failure in patients with hepatocellular carcinoma", Ann Surg, 265, pp.1201~1208 (2017)
- Chong CC, "Liver stiffness measurement predicts high-grade post-hepatectomy liver failure : a prospective cohort study", J Gastroenterol Hepatol, 32, pp.506~514 (2017)